Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein

Analysts See 'Historic Dislocation' Between Gold Prices and Miner Valuations

Shareholders who lost money on DoubleVerify Holdings, Inc. (NYSE: DV) Should Contact Wolf Haldenstein

Shareholders who lost money on Red Cat Holdings, Inc. (NASDAQ: RCAT) Should Contact Wolf Haldenstein

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Luminar Technologies, Inc. - LAZR

GSK invests $300,000 to help launch the Pharmacy Innovation in Immunization Research Collaborative (PIIRC) at the University of Waterloo...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

Isha Foundation’s Meditation App Surpasses ChatGPT’s Launch Pace, Signals Global Demand for Digital Stillness

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meta Platforms, Inc. - META

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class Action Lawsuit and...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX

Global PoE Switch Market Set for 7.2% CAGR Growth as IP Devices and Smart Cities Expand ' | Valuates Reports'

National Advertising Division Finds Certain Boxed Water is Better® Environmental Claims Supported; Recommends Others be Modified or...

Rocketseed launches essential email signature guide for healthcare organizations

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apple Inc. - AAPL

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Lyons Roofing: Tucson's Premier Roofing Contractor for Professional Roof Replacement

Ferrovial acquires a 5.06% stake in the 407 ETR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT